Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy

Although corticosteroids are currently the first-choice drug for thyroid eye disease (TED), in 20–30% of cases, patients show poor or non-existent responses, and when the drug is withdrawn, 10–20% of patients relapse. Thus, in this study, we aimed to investigate the efficacy of the combined use of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Mohammad Taher, Rafizadeh, Seyed Mohsen, Mohammadi, Abbas, Eshraghi, Bahram, Mohammadi, Nader, Hosseini, Seyedeh Simindokht, Rajabi, Mohammad Bagher, Keshmirshekan, Mohammad Mohsen, Shahriari, Mansoor, Poursayed Lazarjani, Seyedeh Zahra, Parandin, Mohammad Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873183/
https://www.ncbi.nlm.nih.gov/pubmed/35223896
http://dx.doi.org/10.3389/fmed.2022.788228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873183/
https://www.ncbi.nlm.nih.gov/pubmed/35223896
http://dx.doi.org/10.3389/fmed.2022.788228

Ejemplares similares